Safety and Efficacy of TOP1630 for Dry Eye Syndrome

Summary

In subjects with Dry Eye Syndrome: The primary objective of this study is to compare the safety and tolerability of TOP1630 Ophthalmic Solution to placebo. The secondary objectives are to compare the efficacy of TOP1630 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Timeline

Start

2017-02-20

Primary completion

2017-06-15

Completion

2017-06-15

Drugs

Indications